A NOVEL STABILITY-INDICATING RP-UPLC METHOD FOR THE QUANTIFICATION OF IMPURITIES AND A NEW QDa MASS DETECTOR COUPLED WITH LC-PDA FOR IDENTIFICATION OF MASS OF DEGRADATION PRODUCTS IN A FIXED DOSE COMBINATION OF EMPAGLIFLOZIN AND LANIGLIPTIN TABLETS USED AS SECOND-LINE THERAPY FOR TYPE-2 DIABETES

2018 ◽  
Vol 9 (7) ◽  
pp. 192-201
Author(s):  
Varaprasad Jagadabi ◽  
P V Nagendra Kumar ◽  
Srinivasu Pamidi ◽  
L A Ramaprasad ◽  
D Nagaraju
Keyword(s):  
Type 2 Diabetes ◽  
Degradation Products ◽  
Fixed Dose Combination ◽  
Fixed Dose ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy ◽  
Mass Detector ◽  
Dose Combination

Individualized HbA1c Targets in People with Type 2 Diabetes Initiating Second-Line Therapy—The Global DISCOVER Study

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1629-P
Author(s):  
KAMLESH KHUNTI ◽  
HUNGTA CHEN ◽  
JAVIER CID-RUZAFA ◽  
PETER FENICI ◽  
MARILIA B. GOMES ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy

135-OR: The Effect of Fixed-Dose Combination of Insulin Degludec and Liraglutide on Serum Lipoprotein Metabolism in Patients with Type 2 Diabetes Mellitus

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 135-OR
Author(s):  
ELENI PAPPA ◽  
CHRISTINA KOSTARA ◽  
CONSTANTINOS TELLIS ◽  
ALEXANDROS D. TSELEPIS ◽  
ELENI BAIRAKTARI ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Lipoprotein Metabolism ◽  
Serum Lipoprotein ◽  
Insulin Degludec ◽  
Fixed Dose Combination ◽  
Fixed Dose ◽  
Dose Combination

scholarly journals Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin

Diabetes Care ◽  
2015 ◽  
Vol 38 (3) ◽  
pp. 384-393 ◽  
Author(s):  
Ralph A. DeFronzo ◽  
Andrew Lewin ◽  
Sanjay Patel ◽  
Dacheng Liu ◽  
Renee Kaste ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy
Sign in / Sign up

Export Citation Format

Share Document